Bevacizumab for recurrent primary central nervous system lymphoma: A new treatment?

Karina Nieto, Leo I Gordon, Jeffrey J Raizer

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)1648-1649
Number of pages2
JournalNeuro-Oncology
Volume17
Issue number12
DOIs
StatePublished - Jan 1 2015

Fingerprint

Angiogenesis Inhibitors
Methotrexate
Brain Neoplasms
Non-Hodgkin's Lymphoma
Lymphoma
Central Nervous System
Bevacizumab

Keywords

  • Bevacizumab
  • PCNSL

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Nieto, Karina ; Gordon, Leo I ; Raizer, Jeffrey J. / Bevacizumab for recurrent primary central nervous system lymphoma : A new treatment?. In: Neuro-Oncology. 2015 ; Vol. 17, No. 12. pp. 1648-1649.
@article{e2b878bd199d4de299f94756707109c8,
title = "Bevacizumab for recurrent primary central nervous system lymphoma: A new treatment?",
keywords = "Bevacizumab, PCNSL",
author = "Karina Nieto and Gordon, {Leo I} and Raizer, {Jeffrey J}",
year = "2015",
month = "1",
day = "1",
doi = "10.1093/neuonc/nov246",
language = "English (US)",
volume = "17",
pages = "1648--1649",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "12",

}

Bevacizumab for recurrent primary central nervous system lymphoma : A new treatment? / Nieto, Karina; Gordon, Leo I; Raizer, Jeffrey J.

In: Neuro-Oncology, Vol. 17, No. 12, 01.01.2015, p. 1648-1649.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Bevacizumab for recurrent primary central nervous system lymphoma

T2 - A new treatment?

AU - Nieto, Karina

AU - Gordon, Leo I

AU - Raizer, Jeffrey J

PY - 2015/1/1

Y1 - 2015/1/1

KW - Bevacizumab

KW - PCNSL

UR - http://www.scopus.com/inward/record.url?scp=84958542485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958542485&partnerID=8YFLogxK

U2 - 10.1093/neuonc/nov246

DO - 10.1093/neuonc/nov246

M3 - Letter

VL - 17

SP - 1648

EP - 1649

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 12

ER -